Gastrointestinal stromal tumors (GIST) have been regarded as rare tumor man
ifestations of the mesenchymal tissue fraction of the intestinal building p
rinciple; however, this tumor is now established as an independent tumor en
tity owing to independent immunohistochemical and ultrastructural character
istics. In spite of increasing awareness of their biological behavior and t
heir molecular-biological basis, evaluating the grade of many of these tumo
rs remains open, not only on a preoperative but also on a postoperative bas
is. Thus, how radical the surgical procedure must be is not standardized, a
s it is in carcinoma surgery. The literature available today is not suffici
ent to make a valid analytical assummption possible because of small number
s of cases and the heterogeneity of clinical and pathological variables. Th
erefore, recommendations concerning oncological-surgical radicality have at
this time an empirical character. Owing to the rarity of the tumor, this w
ill probalby not change in the near future. Adjuvant therapeutical treatmen
t of relevant effectiveness does not exist. Therefore, the radicalnes of th
e operation is organ-specific, tumor-specific and based on tumor-biological
criteria.